Mpox surge in Central Africa exposes the most vulnerable

[August 21, 2024]  By Djaffar Al Katanty

KANYARUTSHINYA CAMP, Democratic Republic of Congo (Reuters) - Justine Munguiko could not recall the name of the disease she had been warned about. She knew only that her baby Fidele had painful sores similar to those suffered by other children at the displacement camp near the eastern Congolese city of Goma.

Democratic Republic of Congo is the epicenter of an mpox outbreak that the World Health Organization last week declared to be a global public health emergency. Communities like Munguiko's are among the most exposed and in need of support.

She and other mothers at the camp decided to treat their children in a traditional way for dealing with fevers and rashes: washing them in boiled salty water and rubbing their skin with the soft leaves of the Kitamatama plant.

"This disease of skin lesions, comes from I don't know where... We've been told it comes after eating bushmeat, but neither I nor my child have eaten bushmeat," the 24-year-old said, after trying to soothe her crying baby, who still had crusty sores on his wrists and feet.

As the international community struggles to source enough vaccines, Munguiko's experience highlights the amount of work needed to ensure the most vulnerable have the knowledge and resources to protect themselves from the viral infection that is usually mild, but can kill.

Communicating with people about what they should do is critical, said Ebere Okereke, associate fellow at Chatham House's Global Health Program.

"We need to get the right information out to the people who are immediately at risk," she told Reuters.

There have been around 27,000 cases and more than 1,100 deaths, mainly among children, in Congo since the current outbreak began in January 2023. The virus has also spread to nearby countries.

Patients receive breakfast at the Mpox treatment centre in Munigi, Nyiragongo territory, near Goma in North Kivu province of the Democratic Republic of Congo August 19, 2024. REUTERS/Arlette Bashizi

At Kanyarutshinya camp on Monday, residents gathered in an open area between the rows of tents to hear a health worker from aid organization Medair explain how to avoid infection. They received a colorful leaflet with pictures showing the risk of close contact with infected animals or people.

The challenge in Congo and other African countries is compounded by a lack of funding for research, said Helen Rees, co-chair Of South Africa’s mpox incident management team.

"We still globally do not have a good understanding of mpox ... outbreaks, how it spreads, how many asymptomatic cases we have for every case that we find with symptoms," she told Reuters.

Those on the ground are eager to learn more also. Camp resident Bizimungu Habimana, 46, examined the leaflet closely after the Medair presentation.

"We thought there was no medicine or cure for this disease. I'm so glad to hear it's curable," he said.

(Additional reporting by Cooper Inveen in Dakar, Catherine Schenk in Johannesburg, Ange Kasongo and Benoit Nyemba in Kinshasa; Writing by Alessandra Prentice; editing by Barbara Lewis)

[© 2024 Thomson Reuters. All rights reserved.]This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.